AbbVie shares tumble after schizophrenia drug disappoints

1 week ago 3
Add to circle
US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptoms
Read Entire Article
  1. Homepage
  2. Business
  3. AbbVie shares tumble after schizophrenia drug disappoints

Related

Germany accuses Azerbaijan of backing oil and gas hijack of COP29

Germany accuses Azerbaijan of backing oil and gas hijack of ...

53 minutes ago 0
Meta loses ground to Bluesky as users abandon Elon Musk’s X

Meta loses ground to Bluesky as users abandon Elon Musk’s X

1 hour ago 0
German bond investors bet on an end to Berlin’s ‘debt brake’

German bond investors bet on an end to Berlin’s ‘debt brake’...

1 hour ago 0